Found: 7
Select item for more details and to access through your institution.
Optimizing Dosing and Fixed-Dose Combinations of Rifampicin, Isoniazid, and Pyrazinamide in Pediatric Patients With Tuberculosis: A Prospective Population Pharmacokinetic Study.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. 141, doi. 10.1093/cid/ciab908
- By:
- Publication type:
- Article
Clinical and Cardiac Safety of Long-term Levofloxacin in Children Treated for Multidrug-resistant Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 11, p. 1777, doi. 10.1093/cid/ciy416
- By:
- Publication type:
- Article
Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.722204
- By:
- Publication type:
- Article
Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2021, v. 10, n. 2, p. 201, doi. 10.1093/jpids/piaa039
- By:
- Publication type:
- Article
Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pharmacokinetics of adjusted-dose 8-hourly lopinavir/ritonavir in HIV-infected children co-treated with rifampicin.
- Published in:
- 2019
- By:
- Publication type:
- journal article